William Pickering
Stock Analyst at Bernstein
(3.10)
# 2,871
Out of 4,479 analysts
16
Total ratings
66.67%
Success rate
7.48%
Average return
Main Sectors:
Top Industries:
10 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IONS Ionis Pharmaceuticals | Upgrades: Market Perform | n/a | $47.11 | - | 2 | Jun 14, 2024 | |
| REGN Regeneron Pharmaceuticals | Initiates: Outperform | $1,125 | $1,057.02 | +6.43% | 1 | Mar 12, 2024 | |
| VRTX Vertex Pharmaceuticals | Downgrades: Market Perform | n/a | $471.25 | - | 5 | Feb 2, 2024 | |
| BMRN BioMarin Pharmaceutical | Upgrades: Market Perform | $82 | $82.13 | -0.16% | 2 | Oct 23, 2023 | |
| ALNY Alnylam Pharmaceuticals | Initiates: Outperform | $243 | $243.32 | -0.13% | 1 | Mar 21, 2023 | |
| NTLA Intellia Therapeutics | Initiates: Outperform | $54 | $22.47 | +140.32% | 1 | Mar 21, 2023 | |
| BEAM Beam Therapeutics | Initiates: Market Perform | $37 | $23.05 | +60.52% | 1 | Mar 21, 2023 | |
| ALLO Allogene Therapeutics | Initiates: Market Perform | $6 | $2.33 | +157.51% | 1 | Mar 21, 2023 | |
| CRSP CRISPR Therapeutics AG | Initiates: Market Perform | $44 | $53.95 | -18.44% | 1 | Mar 21, 2023 | |
| ARWR Arrowhead Pharmaceuticals | Initiates: Market Perform | $27 | $26.05 | +3.65% | 1 | Mar 21, 2023 |
Ionis Pharmaceuticals
Jun 14, 2024
Upgrades: Market Perform
Price Target: n/a
Current: $47.11
Upside: -
Regeneron Pharmaceuticals
Mar 12, 2024
Initiates: Outperform
Price Target: $1,125
Current: $1,057.02
Upside: +6.43%
Vertex Pharmaceuticals
Feb 2, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $471.25
Upside: -
BioMarin Pharmaceutical
Oct 23, 2023
Upgrades: Market Perform
Price Target: $82
Current: $82.13
Upside: -0.16%
Alnylam Pharmaceuticals
Mar 21, 2023
Initiates: Outperform
Price Target: $243
Current: $243.32
Upside: -0.13%
Intellia Therapeutics
Mar 21, 2023
Initiates: Outperform
Price Target: $54
Current: $22.47
Upside: +140.32%
Beam Therapeutics
Mar 21, 2023
Initiates: Market Perform
Price Target: $37
Current: $23.05
Upside: +60.52%
Allogene Therapeutics
Mar 21, 2023
Initiates: Market Perform
Price Target: $6
Current: $2.33
Upside: +157.51%
CRISPR Therapeutics AG
Mar 21, 2023
Initiates: Market Perform
Price Target: $44
Current: $53.95
Upside: -18.44%
Arrowhead Pharmaceuticals
Mar 21, 2023
Initiates: Market Perform
Price Target: $27
Current: $26.05
Upside: +3.65%